Treatment of Paralysis Caused by West Nile Virus in Hamsters

Authors

John D. Morrey, Utah State UniversityFollow
V. Siddharthan, Utah State UniversityFollow
H. Wang, Utah State UniversityFollow
Aaron L. Olsen, Utah State UniversityFollow
Ramona T. Skirpstunas, Utah State UniversityFollow
Jeffery O. Hall, Utah State UniversityFollow
H. Li
S. Koenig
S. Johnson
J. L. Nordstrom
N. Marlenee
R. A. Bowen
M. S. Diamond

Document Type

Article

Journal/Book Title/Conference

Antiviral Research

Volume

74

Issue

3

Publisher

Elsevier

Publication Date

2007

First Page

A32

Last Page

A32

Abstract

WNV-specific humanized monoclonal antibody (hE16) was used to treat WNV-induced poliomyelitis and fatal WNV-aerosolization when administered as a single intraperitoneal (i.p.) injection days after the virus had infected the spinal cord of rodents.

Comments

Originally published by Elsevier. Publisher's PDF and HTML fulltext available through remote link.

Recommended Citation

Morrey, J.D., V. Siddharthan, H. Wang, A.L. Olsen, R. Skirpstunas, J. O. Hall, H. Li, S. Koenig, S. Johnson, J. L. Nordstrom, N. Marlenee, R. A. Bowen and M.S. Diamond 2007. Treatment of Paralysis Caused by West Nile Virus in Hamsters. Antiviral Research, 74 (3): A32.